15 News by Angiotech Pharmaceuticals

Tip: You can further refine your news selection by topics, departments and industries.

15 News by Angiotech Pharmaceuticals

Tip: You can further refine your news selection by topics, departments and industries.

Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

27-Sep-2010 - Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The ...

acute myocardial infarction allergic reactions cardiology

Angiotech announces positive results from Bio-Seal(TM) clinical study

12-Mar-2009 - Angiotech Pharmaceuticals, Inc. announced positive clinical study results for its Bio-Seal(TM) Lung Biopsy Tract Plug System at the Society of Interventional Radiologists Annual Scientific Meeting in San Diego, CA. The trial assessed the safety and efficacy of Bio-Seal in patients undergoing lung ...

lung cancer tubes

Angiotech announces director resignation

17-Apr-2008 - Angiotech Pharmaceuticals, Inc. announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned to enable him to focus on his numerous business pursuits and additional board appointments. Mr. Peet has served on Angiotech's Board of ...

Angiotech receives favourable decision from the European Patent Office EPO

19-Mar-2007 - Angiotech Pharmaceuticals, Inc. announced a favourable decision regarding its Hunter Patent from the European Patent Office (EPO) in Munich, Germany. The EPO's Technical Board of Appeal rejected the attempt by Conor Medsystems Inc. and Sahajanand Medical Technologies Pvt. Ltd. to intervene and ...

Germany

Angiotech Pharmaceuticals to acquire Quill Medical Inc.

29-May-2006 - Angiotech Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire privately held Quill Medical, Inc., a provider of specialized, minimally invasive aesthetic surgery and wound closure technology, for US $40 million in cash, plus certain future contingent ...

license agreements surgery

Angiotech Pharmaceuticals and Genzyme Corporation Form Collaboration to Develop Innovative Surgical Oncology Treatments

11-May-2006 - Angiotech Pharmaceuticals, Inc. and Genzyme Corporation announced that they have entered into a strategic collaboration agreement designed to identify, develop and commercialize innovative therapies for cancer patients undergoing surgical removal of tumors. Angiotech and Genzyme will collaborate ...

biology biomaterials drug screening

Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands

05-May-2006 - Boston Scientific Corporation and Angiotech Pharmaceuticals, Inc. announced that they received a favorable decision from a Dutch court in a patent dispute against Sahajanand Medical Technologies Pvt. Ltd. Boston Scientific and Angiotech alleged that Sahajanand's Infinnium paclitaxel-eluting stent ...

Netherlands patent infringement

CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Interventional Medicines

18-Apr-2006 - CombinatoRx, Incorporated and Angiotech Pharmaceuticals, Inc. announced a multi-year research and license agreement for the discovery, development, and potential commercialization by Angiotech of drug devices and interventional medicine products built from innovative drug combinations. The ...

license agreements medical devices medicine

Angiotech Pharmaceuticals Closes Acquisition of American Medical Instruments Holdings, Inc.

27-Mar-2006 - Angiotech Pharmaceuticals announced that it has closed the previously announced acquisition of American Medical Instruments Holdings, Inc. (AMI), a leading independent manufacturer of specialty, single-use medical devices, for approximately US $785 million in cash subject to post-closing ...

medical devices

Angiotech to appeal UK judgment regarding UK patent

28-Feb-2006 - Angiotech Pharmaceuticals, Inc. announced that it intends to appeal a UK trial court decision to revoke Angiotech's UK designation of its European Patent No. 0,706,376. The UK trial court ruled that Angiotech's UK Patent lacked inventive step in light of certain prior art in a challenge brought ...

patents
Search all
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,240 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now